Foundation

The aim of the Reeve Foundation’s new Quality of Life (QOL) grants program is to address social isolation during the COVID-19 pandemic with the goal of enhancing connectedness of people living with paralysis and their caregivers to their communities and preventing adverse health outcomes.

Though we are looking to the field for innovative ways to address the program’s aim and goals, funds may support programs and projects to:

• Connect isolated individuals and remotely foster engagement and connection through
  • Virtual support groups
  • Online activities to help support self-care and stress management
  • Virtual and online adaptive physical activity and health promotion programs
  • Art sessions
  • Gaming
• Adapt services or create new services to continue to support and engage family caregivers
• Facilitate connection through the use of technology, including
  • Increasing access to internet, broadband service, and tablets (via loan closets)
• Provide programs with online opportunities for volunteering (Volunteering has been shown to have many positive health benefits)
• Create strategies to strengthen and/or build social networks
• Provide access to tools and resources to help people remain connected and engaged

It is expected that between six to ten grants will be awarded within the range of $25,000-$50,000.

The Foundation for a Smoke-free World is seeking to conduct research at the nexus of COVID-19, smoking, and nicotine that will require significant collaboration and research efforts with outside experts and organizations. We seek to advance knowledge of value to science and policy in these areas. The selected organization(s) will implement a range of projects relevant to the global pandemic, including well-designed and comprehensive pre-clinical, clinical, and epidemiological studies, to better understand the associations between smoking and / or nicotine use, and COVID-19 infection and outcomes.

This call for proposals (CFP) will provide supplemental research funding to teams that are already engaged in the study of a promising system alignment mechanism, with the objective of learning how this mechanism performs in addressing health and social needs during the COVID-19 pandemic.

The need to identify successful system alignment strategies has become increasingly urgent in the wake of the SARS-CoV-2 virus pandemic that causes COVID-19. This pandemic places people with unmet health and social needs at heightened risk of infection and complications, while propagating unmet needs through job losses, school and business closures, occupational risks, and social distancing policies. This call for proposals (CFP) will provide supplemental research funding to teams that are already engaged in the study of a promising system alignment mechanism, with the objective of learning how this mechanism performs in addressing health and social needs during the COVID-19 pandemic.

Eligible teams must have an active or recently completed research study (within 12 months of application submission) that can be extended through the use of supplemental research funding. This CFP is appropriate for studying an existing system alignment mechanism implemented prior to the arrival of the COVID-19 pandemic, and about which some pre-COVID evidence has already been created by the applicant. Studies funded through the S4A program must test a specific system alignment mechanism that engages all three of the sectors referenced in this call—medical care, public health, and social services.

Rihanna's Clara Lionel Foundation, in partnership with Twitter and Square CEO Jack Dorsey's #startsmall initiative, has announced grants totaling $15 million in support of efforts to address racial injustice and the impacts of the COVID-19 pandemic. Grants were awarded to nonprofits working to address mental health issues, food insecurity, income loss, and the needs of individuals excluded from federal stimulus programs.

Healthy Eating Research is a national program through the RWJ Foundation; inform decision-making regarding Federal Nutrition Assistance Programs. 1) Issue Briefs/Commentaries: up to $3k for 6 mo.; distill existing research into easily digestible brief format for an advocate or policymaker audience; 2) Papers/research reviews: $5-8k for 6 mo.; peer reviewed manuscript or HER-branded research product; or 3) Small studies: up to $50k for 9 mo.; explore the impact of COVID-19 pandemic on nutrition, diet quality, food security, and related health consequences for children and families.

Our work to improve diagnostic performance will focus on three clinical categories – acute vascular events, infections and cancers. As we embark on this work, our primary strategy is to strengthen accountability for diagnostic excellence by helping to develop and validate new measures for diagnostic performance. In addition, we will look at opportunities to support growth and capacity of the field – preparing leaders dedicated to working on the issue of diagnostic excellence. And, we will assess the potential for new technologies to improve diagnostic performance, working to both minimize barriers for innovation and advocate for the safe and responsible deployment of these technologies. 

One of the 23 NYC Foundations taking part in the NYC Covid-19 Response and Impact Fund, a philanthropic partnership to aid New York nonprofit service providers struggling with the health and economic effects of the pandemic. Nonprofits addressing healthcare and food insecurity as well as arts and culture will be given priority.

Grant funding may be used to provide direct assistance to economically vulnerable individuals and families impacted by COVID 19. Such assistance may include the provision of food, housing, utilities, transportation, childcare, education, and/or health services. Grant funding may not be utilized to develop or implement new programs or services not in place prior to March 11, 2020

COVID 19 Therapeutics Accelerator - $150 million: The funding will help strengthen detection, isolation and treatment efforts; protect at-risk populations; and develop vaccines, treatments and diagnostics. The R&D efforts are focused on developing new drugs, as well as exploring the possibilities to repurpose existing medicines. This work will leverage the power of partnership to develop, manufacture, and distribute effective treatments—and quickly. The COVID-19 Therapeutics Accelerator will not be conducting a traditional funding call. To learn more about the funding process, or how to invest in the accelerator, contact epidemics@wellcome.ac.uk (opens in a new tab).
The COVID-19 Therapeutics Accelerator will work closely with the World Health Organization, government and private sector funders, and global regulatory and policy-setting institutions. It will have an end-to-end focus – from drug pipeline development through to manufacturing and scale-up – and will provide fast and flexible funding at key stages of the process.

Carlos Slim Foundation allocates 1bn pesos US ($41 million) for Covid-19 prevention and treatment in Mexico. The donation will go toward the purchase of medical equipment and public health educational resources